ALTERITY THERAPEUTICS LTD (ATHE) Form 6-K — Aug 14, 2026

Alterity Therapeutics Limited filed a Form 6-K dated August 14, 2026 as a foreign private issuer covering its August 2026 report obligations, incorporating the filing into its existing S-8 and F-3 registration statements. The sole substantive exhibit (99.1) is titled 'Application for quotation of securities - ATH,' an Australian Securities Exchange quotation application typically filed when newly issued shares are to be quoted. The exhibit was furnished only as an image, so no share counts, prices, or issuance details are extractable from this filing. No quantitative figures appear anywhere in the filing text, and the registrant is described as a development stage enterprise.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.